地特胰岛素联合格列美脲对2型糖尿病的疗效观察(3)
第1页 |
参见附件。
[参考文献]
[1] Blonde L,Merilainen M,Karwe V,et al. Patient-directedtitration for achieving glycaemic using a once-daily basal insulin analogue:an assessment of two different fasting plasma glucose targets-the TITRATETM study [J]. Diabetes Obes Metab,2009,11:623-631.
[2] Yenigun M,Honka M. Switching patients from insulin glargine-based basal-bolus regimens to a once daily insulin detemir-based basal-bolus regimens:results from a subgroup of the PREDICTIVETM study [J]. Int J Clin Pract,2009,63:425-432.
[3] 陈灏珠,林果为.实用内科学[M].13版.北京:人民卫生出版社,2009:1028.
[4] 高妍.地特胰岛素:一种安全的基础胰岛素类似物[N].中国医学论坛报,2011-03-08.
[5] Meneghini LF,Rosenberg KH,Koenen C,et al. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine:clinical practice experience from a German subgroup of the PREDICTIVE study [J]. Diabetes Obes Metab,2007,9(3):418-427.
[6] 傅嘉颖.2型糖尿病患者口服降糖联合地特胰岛素或甘精胰岛素的临床效果研究[J].海峡药学,2012,4(2):155-156.
[7] 张茜,李涛,张涛,等.地特胰岛素治疗2型糖尿病的临床观察[J].临床合理用药杂志,2012,5(1):24.
[8] 张秀华,张志华.地特胰岛素联合拜糖平治疗初诊2型糖尿病[J].实用糖尿病杂志,2011,(2):54.
[9] Eldor R,Stern E,Milicevic Z,et al. Early use of insulin in type 2 diabetes [J]. Diabetes Res Clin Pract,2005,68(1):30-35.
[10] 张敏华,吴金锴.地特胰岛素联合阿卡波糖治疗2型糖尿病疗效观察[J].海峡药学,2011,3(2):139-140.
(收稿日期:2012-06-14 本文编辑:张瑜杰)
您现在查看是摘要介绍页,详见PDF附件(3255kb)。